In quest to beat COVID-19, Bay Area biotech closes Big Pharma equity deal for $250M By: San Francisco Business Times via Business Journals April 06, 2020 at 10:31 AM EDT The companies hope to push two antibodies into mid-stage clinical trials within three to five months. Read More >>
